Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,495,748
+$637,533 QoQ
Shares Held
5,944
+50.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2,178
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resurgent Financial Advisors LLC holds $18,383,670 across 8 Drug Manufacturers - General names. ABBV ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,580 | $6,692,819 | |
| 2 | JNJ |
Johnson & Johnson
|
22,360 | $5,678,769 | |
| 3 | AMGN |
Amgen Inc
|
4,679 | $1,694,359 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
5,944 | $1,495,748 | |
| 5 | PFE |
Pfizer Inc
|
52,559 | $1,265,620 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,331 | $942,033 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,796 | $391,585 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,763 | $222,737 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,495,748 | 5,944 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $858,215 | 3,946 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $629,261 | 2,754 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $643,218 | 2,778 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $527,346 | 2,841 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $598,808 | 2,858 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $577,702 | 3,251 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $633,713 | 3,209 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $447,838 | 2,611 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $465,083 | 2,554 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $411,290 | 2,654 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $463,278 | 3,108 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $417,797 | 3,101 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $470,778 | 2,954 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,097,493 | 6,791 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $980,135 | 7,303 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,083,147 | 7,072 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,072,843 | 6,618 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $358,133 | 2,645 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||